Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zeng H"" wg kryterium: Autor


Tytuł:
Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
Autorzy:
Chen L; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zeng H; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Du Z; West China School of Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhao Y; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ma X; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2020; Vol. 29 (1), pp. 151-161.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Biomarkers, Tumor/*blood
Head and Neck Neoplasms/*blood
Inflammation/*blood
Adult ; Aged ; Blood Platelets/pathology ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Inflammation/pathology ; Kaplan-Meier Estimate ; Lymphocytes/pathology ; Male ; Middle Aged ; Neutrophils/pathology ; Nomograms ; Sarcoma/pathology
Czasopismo naukowe
Tytuł:
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma.
Autorzy:
Chen L; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Zeng H; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Yang J; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Lu Y; The People's Hospital of Hechi, Hechi, Guangxi, People's Republic of China.
Zhang D; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Wang J; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Kuang C; West China School of Stomatology, Sichuan University, Chengdu, People's Republic of China.
Zhu S; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Wang M; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China.
Ma X; Department of Biotherapy, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, No.37, Guoxue Alley, Chengdu, 610041, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Aug 13; Vol. 18 (1), pp. 816. Date of Electronic Publication: 2018 Aug 13.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Carcinoma, Squamous Cell/*blood
Head and Neck Neoplasms/*blood
Inflammation/*blood
Laryngeal Neoplasms/*blood
Adult ; Aged ; Carcinoma, Squamous Cell/pathology ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Inflammation/pathology ; Kaplan-Meier Estimate ; Laryngeal Neoplasms/pathology ; Lymphocytes/pathology ; Male ; Middle Aged ; Monocytes/pathology ; Neutrophils/pathology ; Platelet Count ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe
Tytuł:
Magnetic resonance imaging evaluation of treatment efficacy and prognosis for brain metastases in lung cancer patients after radiotherapy: A preliminary study.
Autorzy:
Liu Y; Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Liu X; Department of Thoracic Surgery, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Xu L; Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Liu L; Department of Radiology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Sun Y; Department of Pathology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Li M; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Zeng H; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Yuan S; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Yu J; Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2018 Jul; Vol. 9 (7), pp. 865-873. Date of Electronic Publication: 2018 May 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prognosis*
Brain Neoplasms/*radiotherapy
Lung Neoplasms/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/pathology ; Brain Neoplasms/secondary ; Diffusion Magnetic Resonance Imaging ; Female ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł:
The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.
Autorzy:
Jiang D; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Li X; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Wang H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Shi Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Xu C; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Lu S; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Huang J; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Xu Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Zeng H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. zeng..
Su J; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Hou Y; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Tan L; Department of Thorax Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2015 May 08; Vol. 15, pp. 377. Date of Electronic Publication: 2015 May 08.
Typ publikacji:
Journal Article
MeSH Terms:
Prognosis*
Biomarkers, Tumor/*biosynthesis
Carcinoma, Squamous Cell/*genetics
ErbB Receptors/*biosynthesis
Esophageal Neoplasms/*genetics
Aged ; Biomarkers, Tumor/genetics ; Carcinoma, Squamous Cell/pathology ; Disease-Free Survival ; ErbB Receptors/genetics ; Esophageal Neoplasms/pathology ; Esophageal Squamous Cell Carcinoma ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; In Situ Hybridization, Fluorescence ; Lymphatic Metastasis ; Male ; Middle Aged
Czasopismo naukowe
Tytuł:
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
Autorzy:
Liu Y
Fu B
Yu Z
Song G
Zeng H
Gong Y
Ding Y
Huang D
Pokaż więcej
Temat:
krba1
prognosis
biomarker
immune infiltration
hepatocellular carcinoma
m6a modification
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Źródło:
Journal of Hepatocellular Carcinoma, Vol Volume 9, Pp 497-516 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/identification-of-krba1-as-a-potential-prognostic-biomarker-associated-peer-reviewed-fulltext-article-JHC; https://doaj.org/toc/2253-5969
Dostęp URL:
https://doaj.org/article/c8b4b3e7dedd4ef0804c736bb99c74a6  Link otwiera się w nowym oknie
Czasopismo naukowe
Czasopismo naukowe
Tytuł:
IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung Cancer
Autorzy:
Chen X
He YQ
Miao TW
Yin J
Liu J
Zeng HP
Zhu Q
Pokaż więcej
Temat:
immediate early response 5 like
non-small cell lung cancer
pan-cancer
prognosis
immune infiltration.
Medicine (General)
R5-920
Źródło:
International Journal of General Medicine, Vol Volume 16, Pp 5889-5908 (2023)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/ier5l-is-a-prognostic-biomarker-in-pan-cancer-analysis-and-correlates--peer-reviewed-fulltext-article-IJGM; https://doaj.org/toc/1178-7074
Dostęp URL:
https://doaj.org/article/5088f49754f44647a85bdff757a36b88  Link otwiera się w nowym oknie
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies